NM_181078.3(IL21R):c.1034G>A (p.Gly345Asp) AND Inborn genetic diseases

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Aug 11, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002552460.1

Allele description [Variation Report for NM_181078.3(IL21R):c.1034G>A (p.Gly345Asp)]

NM_181078.3(IL21R):c.1034G>A (p.Gly345Asp)

Genes:

LOC130058712:ATAC-STARR-seq lymphoblastoid active region 10626 [Gene]
IL21R-AS1:IL21R antisense RNA 1 [Gene - HGNC]
IL21R:interleukin 21 receptor [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

16p12.1

Genomic location:

Preferred name:

NM_181078.3(IL21R):c.1034G>A (p.Gly345Asp)

HGVS:

NC_000016.10:g.27448700G>A
NG_012222.1:g.51299G>A
NM_021798.4:c.1034G>A
NM_181078.3:c.1034G>AMANE SELECT
NM_181079.4:c.1100G>A
NM_181079.5:c.1100G>A
NP_068570.1:p.Gly345Asp
NP_851564.1:p.Gly345Asp
NP_851565.4:p.Gly367Asp
LRG_731t1:c.1100G>A
LRG_731t2:c.1034G>A
LRG_731:g.51299G>A
LRG_731p1:p.Gly367Asp
LRG_731p2:p.Gly345Asp
NC_000016.9:g.27460021G>A
NM_021798.3:c.1034G>A
NR_037158.1:n.1584C>T

Protein change:

G345D

Links:

dbSNP: rs759242116

NCBI 1000 Genomes Browser:

rs759242116

Molecular consequence:

NM_021798.4:c.1034G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_181078.3:c.1034G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_181079.5:c.1100G>A - missense variant - [Sequence Ontology: SO:0001583]
NR_037158.1:n.1584C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Observations:

Condition(s)

Name:: Inborn genetic diseases
Identifiers:: MeSH: D030342; MedGen: C0950123

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003543460	Ambry Genetics	criteria provided, single submitter (Ambry General Variant Classification Scheme_2022)	Uncertain significance (Aug 11, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003543460

Ambry Genetics

criteria provided, single submitter

(Ambry General Variant Classification Scheme_2022)

Uncertain significance
(Aug 11, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	1	not provided	not provided	1	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV003543460.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	not provided

Description

The c.1100G>A (p.G367D) alteration is located in exon 10 (coding exon 9) of the IL21R gene. This alteration results from a G to A substitution at nucleotide position 1100, causing the glycine (G) at amino acid position 367 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	1	not provided	not provided		1	not provided	not provided	not provided

Last Updated: Oct 14, 2023

ClinVar

Relating variation to medicine